FINN Voices: AI, Biomarkers, and the Race to Save Sepsis Patients with Bobby Reddy, Jr, Prenosis

On this episode host Beth Friedman engages Bobby Reddy, Jr., PhD, Co-founder & CEO, Prenosis. Sepsis kills more people annually than all cancers combined - yet it receives a fraction of the research investment. Beth sits with Bobby Reddy Jr., leading Prenosis, a precision medicine company redefining how hospitals understand and treat their most critically ill patients. Reddy explains why decades of clinical trials for sepsis, acute heart failure, and pneumonia have failed and why the solution lies not in new drugs but in recognizing that these are not single diseases at all. Discover how Prenosis is using AI, deep biomarker data, and real-time EHR integration to characterize each patient's unique biology in under an hour, and what a landmark BARDA-funded trial could mean for the future of critical care.